Archive - August 2018
Novartis and Gilead rival CAR-Ts approved in Europe, but supply capacity in question
Roche Diagnostics’ chief heads for the exit
It’s a no for Yescarta, says NICE on heels of EU approval
NICE rejects Gilead CAR-T cancer cell therapy
NICE says ‘no’ to Gilead’s Yescarta in draft guidelines
Bayer, J&J’s Xarelto fails to hit PhIII targets
Bayer files marketing application for larotrectinib
EU approves first CAR-T therapies